365 related articles for article (PubMed ID: 17974581)
1. Derivation and validation of a urinary excretion function for plutonium based on occupational exposure.
Yadav JR; Rao DD; Hegde AG; Aggarwal SK
Radiat Prot Dosimetry; 2008; 129(4):386-90. PubMed ID: 17974581
[TBL] [Abstract][Full Text] [Related]
2. Validation of a system of models for plutonium decorporation therapy.
Dumit S; Avtandilashvili M; McComish SL; Strom DJ; Tabatadze G; Tolmachev SY
Radiat Environ Biophys; 2019 May; 58(2):227-235. PubMed ID: 30627772
[TBL] [Abstract][Full Text] [Related]
3. Use of faecal excretion function for quick estimation of initial and existing lung burden for occupational exposure control due to 239Pu for S-class of intake.
Yadav JR; Rao DD; Hegde AG; Aggarwal SK
Radiat Prot Dosimetry; 2008; 129(4):403-10. PubMed ID: 18083719
[TBL] [Abstract][Full Text] [Related]
4. A computational study of the urinary excretion rates for 339Pu using new ICRP internal dosimetry models.
Singh IS; Sharma RC; Abani MC
Radiat Prot Dosimetry; 2003; 105(1-4):361-4. PubMed ID: 14526987
[TBL] [Abstract][Full Text] [Related]
5. Three plutonium chelation cases at Los Alamos National Laboratory.
Bertelli L; Waters TL; Miller G; Gadd MS; Eaton MC; Guilmette RA
Health Phys; 2010 Oct; 99(4):532-8. PubMed ID: 20838095
[TBL] [Abstract][Full Text] [Related]
6. Practical action levels for chelation therapy in plutonium inhalation using nose swab.
Kurihara O; Takada C; Takasaki K; Ito K; Momose T; Miyabe K
Radiat Prot Dosimetry; 2007; 127(1-4):411-4. PubMed ID: 17567761
[TBL] [Abstract][Full Text] [Related]
7. Interpretation of Urinary Excretion Data From Plutonium Wound Cases Treated With DTPA: Application of Different Models and Approaches.
Poudel D; Bertelli L; Klumpp JA; Waters TL
Health Phys; 2017 Jul; 113(1):30-40. PubMed ID: 28542009
[TBL] [Abstract][Full Text] [Related]
8. Use of air monitoring and experimental aerosol data for intake assessment for Mayak plutonium workers.
Zaytseva YV; Tretyakov FD; Romanov SA; Miller G; Bertelli L; Guilmette RA
Radiat Prot Dosimetry; 2007; 127(1-4):535-9. PubMed ID: 17848389
[TBL] [Abstract][Full Text] [Related]
9. Comparisons of 239Pu inhalation doses calculated with ICRP 67 and proposed systemic models.
Li WB; Oeh U; Paretzke HG
Radiat Prot Dosimetry; 2007; 127(1-4):148-52. PubMed ID: 17545662
[TBL] [Abstract][Full Text] [Related]
10. Decorporation of plutonium by pulmonary administration of Ca-DTPA dry powder: a study in rat after lung contamination with different plutonium forms.
Sérandour AL; Tsapis N; Gervelas C; Grillon G; Fréchou M; Deverre JR; Bénech H; Fattal E; Fritsch P; Poncy JL
Radiat Prot Dosimetry; 2007; 127(1-4):472-6. PubMed ID: 17562654
[TBL] [Abstract][Full Text] [Related]
11. Biokinetic modelling of DTPA decorporation therapy: the CONRAD approach.
Breustedt B; Blanchardon E; Berard P; Fritsch P; Giussani A; Lopez MA; Luciani A; Nosske D; Piechowski J; Schimmelpfeng J; Sérandour AL
Radiat Prot Dosimetry; 2009 Feb; 134(1):38-48. PubMed ID: 19351653
[TBL] [Abstract][Full Text] [Related]
12. Treatment of actinide exposures: a review of Ca-DTPA injections inside CEA-COGEMA plants.
Grappin L; Berard P; Menetrier F; Carbone L; Courtay C; Castagnet X; Le Goff JP; Neron MO; Piechowski J
Radiat Prot Dosimetry; 2007; 127(1-4):435-9. PubMed ID: 17940101
[TBL] [Abstract][Full Text] [Related]
13. Application of multi-compartment wound models to plutonium-contaminated wounds incurred by former workers at rocky flats.
Falk RB; Daugherty NM; Aldrich JM; Furman FJ; Hilmas DE
Health Phys; 2006 Aug; 91(2):128-43. PubMed ID: 16832194
[TBL] [Abstract][Full Text] [Related]
14. An analysis of a puncture wound case with medical intervention.
Bailey BR; Eckerman KF; Townsend LW
Radiat Prot Dosimetry; 2003; 105(1-4):509-12. PubMed ID: 14527019
[TBL] [Abstract][Full Text] [Related]
15. Interpretation of human urinary excretion of plutonium for cases treated with DTPA.
Jech JJ; Andersen BV; Heid KR
Health Phys; 1972 Jun; 22(6):787-92. PubMed ID: 5084012
[No Abstract] [Full Text] [Related]
16. Modelling of bioassay data from a Pu wound treated by repeated DTPA perfusions: biokinetics and dosimetric approaches.
Fritsch P; Grappin L; Guillermin AM; Fottorino R; Ruffin M; Mièle A
Radiat Prot Dosimetry; 2007; 127(1-4):120-4. PubMed ID: 17562647
[TBL] [Abstract][Full Text] [Related]
17. Twenty-four years of follow-up for a Hanford plutonium wound case.
Carbaugh EH; Lynch TP; Antonio CL; Medina-Del Valle F
Health Phys; 2010 Oct; 99(4):483-94. PubMed ID: 20838089
[TBL] [Abstract][Full Text] [Related]
18. The CONRAD approach to biokinetic modeling of DTPA decorporation therapy.
Breustedt B; Blanchardon E; Bérard P; Fritsch P; Giussani A; Lopez MA; Luciani A; Nosske D; Piechowski J; Schimmelpfeng J; Sérandour AL
Health Phys; 2010 Oct; 99(4):547-52. PubMed ID: 20838097
[TBL] [Abstract][Full Text] [Related]
19. Mayak Worker Dosimetry System 2008 (MWDS-2008): assessment of internal dose from measurement results of plutonium activity in urine.
Khokhryakov VV; Khokhryakov VF; Suslova KG; Vostrotin VV; Vvedensky VE; Sokolova AB; Krahenbuhl MP; Birchall A; Miller SC; Schadilov AE; Ephimov AV
Health Phys; 2013 Apr; 104(4):366-78. PubMed ID: 23439140
[TBL] [Abstract][Full Text] [Related]
20. Americium and plutonium urine excretion following acute inhalation exposures to high-fired oxides.
Hammond SE; Lagerquist CR; Mann JR
Am Ind Hyg Assoc J; 1968; 29(2):169-72. PubMed ID: 5656038
[No Abstract] [Full Text] [Related]
[Next] [New Search]
